Ankyra is a biotech company focused on developing anchored immunotherapy to enhance cancer treatment. The company's innovative approach addresses the challenges associated with traditional cytokine therapeutics, which often face limitations due to widespread immune activation and toxicity when administered systemically. Ankyra utilizes its Anchored Immunotherapy Platform to create ANK-101, a stable complex that combines a modified IL-12 cytokine with an FDA-approved adjuvant, aluminum hydroxide, which helps to retain the cytokine's potent activity at the tumor site. This localized delivery results in targeted inflammation that activates an anti-tumor immune response while minimizing adverse effects. Ankyra aims to optimize the efficacy and safety of its therapies, ultimately improving treatment outcomes for cancer patients.
Orbit Discovery
Venture Round in 2021
Orbit Discovery Ltd. is a biotechnology company based in Oxford, United Kingdom, that specializes in peptide display technology for the identification of peptide drugs aimed at treating chronic diseases. Established in 2015, the company utilizes an innovative in vitro display platform that links randomized peptide sequences to their encoding DNA on small beads, facilitating the screening of potential peptide therapeutics. This approach allows for the discovery of peptides that can offer the specificity and efficacy of larger biologic molecules while maintaining the advantages of smaller molecules, such as reduced dosage and lower manufacturing costs. Orbit Discovery's technology enhances the drug development process by enabling high-throughput screening of peptide candidates, thus supporting both internal drug discovery initiatives and collaborative research efforts.
Ovation offers data and operations solutions tailored for the life sciences industry, focusing on enhancing the capabilities of researchers, scientists, and laboratories. The company has developed a cloud-based laboratory information management system that streamlines clinical diagnostics for molecular diagnostic labs. This system encompasses various functionalities, including lab workflows, sample tracking, document management, personnel training, and external portals. Furthermore, Ovation provides a partner ecosystem that supports revenue cycle management, clinical interpretation, consulting services, and business analytics. By enabling medical researchers and scientists to efficiently collect, organize, and visualize lab-related data, Ovation enhances their ability to make informed decisions throughout the research process.
FidoCure is dedicated to advancing cancer care for dogs through AI-driven precision medicine. The company utilizes data from naturally occurring canine cancers, combining next-generation sequencing with clinical insights to create the largest proprietary learning database for canine oncology. FidoCure offers personalized medicine services that go beyond traditional chemotherapy and radiation, collecting tissue samples for DNA sequencing to identify genetic mutations impacting treatment. This approach allows for the development of targeted therapies aimed at effectively attacking cancer cells. By bridging the gap between human and veterinary oncology, FidoCure enhances comparative oncology, improving treatment outcomes for both pets and humans while addressing a significant unmet need in canine cancer care.
Compass Therapeutics
Private Equity Round in 2020
Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.
Ovation offers data and operations solutions tailored for the life sciences industry, focusing on enhancing the capabilities of researchers, scientists, and laboratories. The company has developed a cloud-based laboratory information management system that streamlines clinical diagnostics for molecular diagnostic labs. This system encompasses various functionalities, including lab workflows, sample tracking, document management, personnel training, and external portals. Furthermore, Ovation provides a partner ecosystem that supports revenue cycle management, clinical interpretation, consulting services, and business analytics. By enabling medical researchers and scientists to efficiently collect, organize, and visualize lab-related data, Ovation enhances their ability to make informed decisions throughout the research process.
Teckro, Inc. is a life science technology company that specializes in transforming clinical trials through its innovative software platform. Founded in 2015 and headquartered in Limerick, Ireland, with additional offices in Dublin and Nashville, Teckro offers solutions that ensure all relevant information is instantly accessible to every active member of a clinical trial. By facilitating seamless connections among investigators, study teams, sites, and patients, Teckro enhances collaboration and knowledge sharing. Its platform employs information retrieval and machine learning technologies to streamline the clinical development process, ultimately improving the speed and accuracy of trials. The company serves pharmaceutical companies and clinical researchers globally, aiming to accelerate the development of drugs and treatments for complex diseases.
Evox Therapeutics
Series B in 2018
Evox Therapeutics Limited is a biotechnology company based in Oxford, United Kingdom, that specializes in developing exosome-based therapeutics for the treatment of severe diseases with limited treatment options. Founded in 2016, the company focuses on harnessing and engineering extracellular vesicles, known as exosomes, to facilitate targeted delivery of nucleic acids and proteins. Evox's innovative platform allows for the modification of exosomes using advanced molecular engineering techniques, enabling effective drug delivery to specific organs, including the brain and central nervous system. By leveraging these natural delivery capabilities, Evox aims to overcome the limitations associated with conventional protein, antibody, and nucleic acid therapies, thereby creating novel therapeutic solutions that could significantly impact human health. The company is supported by a robust intellectual property portfolio and is positioned as a leader in this emerging therapeutic space.
Compass Therapeutics
Series A in 2018
Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.
Orbit Discovery
Series A in 2018
Orbit Discovery Ltd. is a biotechnology company based in Oxford, United Kingdom, that specializes in peptide display technology for the identification of peptide drugs aimed at treating chronic diseases. Established in 2015, the company utilizes an innovative in vitro display platform that links randomized peptide sequences to their encoding DNA on small beads, facilitating the screening of potential peptide therapeutics. This approach allows for the discovery of peptides that can offer the specificity and efficacy of larger biologic molecules while maintaining the advantages of smaller molecules, such as reduced dosage and lower manufacturing costs. Orbit Discovery's technology enhances the drug development process by enabling high-throughput screening of peptide candidates, thus supporting both internal drug discovery initiatives and collaborative research efforts.
Measurabl
Series A in 2018
Measurabl, Inc. is a San Diego-based company that specializes in developing a cloud-based software platform for environmental, social, and governance (ESG) data management, primarily focused on the commercial real estate sector. Founded in 2013, Measurabl's platform enables clients to efficiently collect and analyze non-financial data related to utility usage, waste management, and travel. The software facilitates the creation of investment-grade sustainability reports and provides alerts for improvement opportunities, allowing organizations to benchmark their performance and enhance their ESG initiatives. By empowering customers to assess physical climate risk and drive decarbonization, Measurabl supports the pursuit of sustainable finance opportunities and overall optimization of ESG performance.
Dandelion Energy
Seed Round in 2018
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
Dandelion Energy
Seed Round in 2017
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.
Newmetrix
Series A in 2017
Newmetrix is a technology company that specializes in a cloud-based video management platform aimed at reducing risks on construction sites through the integration of human and artificial intelligence. The platform employs machine learning to analyze images and videos from construction projects, categorizing them with construction-specific tags. This functionality addresses key challenges related to the management, collaboration, search, and analysis of industrial visual content, thereby enhancing safety and operational efficiency for clients in the construction industry.
HELIX, originally known as Flux, is a pioneering company based in Oakland, California, that focuses on simplifying the complexities of building digitization. Initially launched as a project within Google X, HELIX shifted its business model in 2019 to develop the HELIX Creator platform. This platform empowers architects, engineers, builders, and owner-operators to utilize LiDAR and photogrammetry technologies for capturing precise building geometry, facilitating the creation of usable plans and models. By providing accurate 2D and 3D data along with essential documents, HELIX enables users to assess building potential, plan renovations, and document structures for disaster preparedness. The company emphasizes that for Digital Twins to be effective, the underlying data must be accurate, easily accessible, and regularly updated.
Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.
Adored, Inc. is a company based in Manchester, New Hampshire, that offers a mobile loyalty experience platform designed for restaurants, bars, coffee shops, ski resorts, and various attractions. The Adored app utilizes iBeacon indoor location technology to automatically reward customers, fostering stronger relationships between users and the businesses they frequent. By enhancing customer experiences and providing automatic loyalty rewards, Adored aims to increase customer visitation and encourage brand loyalty. The application has been downloaded over 10,000 times and is actively used in numerous locations, allowing businesses to attract new customers and retain existing ones. Founded in 2014, Adored is committed to transforming customer interactions into meaningful experiences that enhance brand value.
Compass Therapeutics
Series A in 2015
Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.
FieldLens
Series A in 2014
FieldLens, Inc. is a technology company that offers an online field management tool designed to enhance communication and collaboration among construction project teams. Established in 2011 and headquartered in New York, New York, FieldLens provides a mobile collaboration platform that enables users to connect from smartphones, tablets, or the web. The platform transforms simple field updates into valuable insights, allowing team members to understand their current tasks and facilitating decision-makers' oversight of projects without the need to be physically present on-site. Additionally, FieldLens automates daily reports, tracks job-site progress in real-time, and helps project leaders identify trends and top performers, ultimately improving efficiency and effectiveness in the construction industry. As of December 2020, FieldLens operates as a subsidiary of RedTeam Software, LLC.
HELIX, originally known as Flux, is a pioneering company based in Oakland, California, that focuses on simplifying the complexities of building digitization. Initially launched as a project within Google X, HELIX shifted its business model in 2019 to develop the HELIX Creator platform. This platform empowers architects, engineers, builders, and owner-operators to utilize LiDAR and photogrammetry technologies for capturing precise building geometry, facilitating the creation of usable plans and models. By providing accurate 2D and 3D data along with essential documents, HELIX enables users to assess building potential, plan renovations, and document structures for disaster preparedness. The company emphasizes that for Digital Twins to be effective, the underlying data must be accurate, easily accessible, and regularly updated.
Sketchfab
Seed Round in 2013
Sketchfab, Inc. is a platform established in 2012 that facilitates the publishing, discovery, and sharing of three-dimensional renderings of objects and content. Headquartered in New York, with an additional office in Paris, Sketchfab aims to empower creativity by enabling users to easily publish and access 3D content online. The platform boasts a community of millions of creators who have contributed millions of models, fostering an environment for immersive and interactive 3D experiences. Additionally, Sketchfab features a marketplace that allows buyers and sellers to confidently transact 3D models, supported by tools such as a real-time viewer and model inspector.
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.
Avedro, Inc. is a commercial-stage ophthalmic pharmaceutical and medical device company headquartered in Waltham, Massachusetts. The company specializes in developing and commercializing innovative products for treating corneal disorders, primarily focusing on corneal ectatic conditions and refractive issues. Avedro's proprietary Corneal Remodeling Platform includes the KXL and Mosaic systems, which utilize ultraviolet A (UVA) light in conjunction with riboflavin drug formulations for corneal cross-linking. This technology is aimed at strengthening and reshaping the cornea through minimally invasive and non-invasive outpatient procedures. Avedro has also introduced the Keraflex refractive correction procedure, a non-invasive technique for flattening the cornea without tissue removal. While Avedro primarily serves ophthalmologists, hospitals, and ambulatory surgery centers in the United States, it also markets its products internationally through medical device distributors. The company, originally named ThermalVision, Inc., was incorporated in 2002 and rebranded as Avedro in 2005. As of November 2019, Avedro operates as a subsidiary of Glaukos Corporation.
Avitide, Inc. specializes in the discovery, manufacture, and supply of molecule-specific affinity purification solutions tailored for the biopharmaceutical industry. Founded in 2012 and based in Lebanon, New Hampshire, the company focuses on developing customized affinity purification products that improve the efficiency and effectiveness of bioprocessing. Avitide's technology enhances the purification of therapeutic proteins, including enzymes, antibodies, gene therapies, and vaccines, by employing rapid development of chromatography resins through chemical synthesis. This advanced platform enables clients to accelerate bioprocess development timelines, mitigate program risks, and achieve predictable commercial scalability while lowering manufacturing costs in both batch and continuous operations.
Mosaic Storage Systems
Series A in 2013
Mosaic Storage Systems is a company based in Nashua, New Hampshire, founded in 2011. It specializes in providing digital asset storage services tailored for professional and prosumer photographers. The company's services involve taking digital copies of photographs, storing them on secure servers, and making them accessible via the internet. This enables users to store and share their photographs securely, ensuring that their valuable assets are protected and easily manageable.
Airstone
Venture Round in 2013
Airstone is a technology company focused on providing specialized Infrastructure as a Service (IaaS) solutions for Big Data customers. The company has developed a proprietary networking fabric known as Ultramarine, which delivers a significant price performance advantage over existing datacenter networking solutions. Ultramarine is distinguished by its low latency and high bandwidth per node, making it a competitive offering in the high-performance computing market. Airstone aims to facilitate advanced computing capabilities for its clients by leveraging its innovative technology.
Vets First Choice
Venture Round in 2012
Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.
PCD Partners
Venture Round in 2011
PCD Partners, Inc. is a company based in Lebanon, New Hampshire, that specializes in developing Web-based platforms for healthcare providers, including physician groups, hospitals, and integrated delivery systems in the United States. The company focuses on enhancing collaboration between hospitals and physicians to improve clinical outcomes and financial performance. PCD Partners offers a co-management solution that facilitates the development of structures aimed at better integration and performance. Additionally, it provides a cloud-based technology platform designed to support alignment structures and quality improvement goals within healthcare organizations. The company also delivers custom Lean Six Sigma training programs and project management software tailored for healthcare delivery, emphasizing measurable results and quality management. With a team of experienced physicians, academics, and entrepreneurs, PCD Partners is dedicated to advancing medical quality and practice improvement systems.
Wingu is focused on enhancing the efficiency of outsourced pharmaceutical research through a metrics-driven software platform. The company develops an enterprise-grade cloud solution that streamlines the management, analysis, and collaboration of scientific data. By simplifying information exchange for researchers and providing comprehensive project insights for managers, Wingu aims to facilitate better decision-making for executives in the pharmaceutical industry. Through its innovative approach, Wingu supports the optimization of research processes, ultimately contributing to improved outcomes in drug discovery.
enVista LLC is a software development and consulting services company based in Carmel, Indiana, with additional offices in Columbus, Mississippi; Liverpool, United Kingdom; Hyderabad, India; and Houston, Texas. Founded in 2002, enVista specializes in providing solutions to manufacturers, distributors, and omni-channel retailers. The company offers a range of supply chain management services, including demand planning, workforce management, program management, facility design, systems selection and implementation, and supply chain partnerships. Additionally, enVista provides global freight audit and payment solutions, transportation consulting, business intelligence dashboards, and various IT services such as cloud computing, cyber security, and managed IT services. The company also offers a unified commerce platform, order management systems, point of sale solutions, product information management, trading partner management, omni-channel fulfillment execution, ecommerce services, and Microsoft business solutions including Power BI, 365, SharePoint Partner, Azure, and Dynamics 365. enVista's expertise in data analytics and artificial intelligence further enhances its ability to help clients reduce operating costs, improve customer service, and enhance profitability across multiple industries.
SpaceClaim
Series D in 2010
SpaceClaim Corporation is a developer of 3D direct modeling software solutions designed to assist engineers, product designers, and manufacturers throughout the product development process. Founded in 2005 and headquartered in Concord, Massachusetts, with additional offices in France and Japan, the company offers several key products, including SpaceClaim Engineer for creating and preparing 3D designs, SpaceClaim Style for industrial design, and SpaceClaim Viewer for accessing and measuring designs. SpaceClaim also provides educational licenses and training programs to support learning institutions in North America. Its software is utilized for various applications, such as conceptual engineering, CAE/model preparation, and manufacturing engineering, and is distributed through a network of resellers both domestically and internationally.
enVista
Debt Financing in 2010
enVista LLC is a software development and consulting services company based in Carmel, Indiana, with additional offices in Columbus, Mississippi; Liverpool, United Kingdom; Hyderabad, India; and Houston, Texas. Founded in 2002, enVista specializes in providing solutions to manufacturers, distributors, and omni-channel retailers. The company offers a range of supply chain management services, including demand planning, workforce management, program management, facility design, systems selection and implementation, and supply chain partnerships. Additionally, enVista provides global freight audit and payment solutions, transportation consulting, business intelligence dashboards, and various IT services such as cloud computing, cyber security, and managed IT services. The company also offers a unified commerce platform, order management systems, point of sale solutions, product information management, trading partner management, omni-channel fulfillment execution, ecommerce services, and Microsoft business solutions including Power BI, 365, SharePoint Partner, Azure, and Dynamics 365. enVista's expertise in data analytics and artificial intelligence further enhances its ability to help clients reduce operating costs, improve customer service, and enhance profitability across multiple industries.
Adimab LLC is a biotechnology company specializing in the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007 and based in Lebanon, New Hampshire, Adimab utilizes a yeast-based platform to create therapeutic antibodies, including IgG and CD3-based bispecific antibodies. The company is recognized for its ability to deliver diverse and high-quality antibody panels that adhere to stringent standards for affinity, epitope coverage, and species cross-reactivity. This capability allows Adimab to support its partners in rapidly expanding their biologics pipelines through various technology access arrangements. The company's work primarily targets the treatment of cancer, autoimmune disorders, and infectious diseases.
Vico Software
Series B in 2009
Vico Software is a provider of software and services tailored for the building construction industry, operating across Europe, the Middle East, and the Americas. Founded in 2007 and headquartered in Boulder, Colorado, the company specializes in a range of solutions that enhance project management and efficiency. Its flagship product, the Vico Office Suite, features a construction-oriented 5D BIM environment, which includes tools such as the Vico Office Client for publishing and integrating 3D models from various sources, and the Vico Takeoff Manager for generating precise quantity takeoffs based on these models. Additionally, Vico Software offers the Vico Cost Planner for cost estimation and value engineering, as well as the Vico Cost Explorer for real-time budget monitoring. The company also provides an online training program to assist users in navigating its software, along with project services delivery and consulting. Vico Software's offerings cater to building owners, general contractors, and construction managers, enhancing their operational capabilities in the construction process.
enVista
Venture Round in 2009
enVista LLC is a software development and consulting services company based in Carmel, Indiana, with additional offices in Columbus, Mississippi; Liverpool, United Kingdom; Hyderabad, India; and Houston, Texas. Founded in 2002, enVista specializes in providing solutions to manufacturers, distributors, and omni-channel retailers. The company offers a range of supply chain management services, including demand planning, workforce management, program management, facility design, systems selection and implementation, and supply chain partnerships. Additionally, enVista provides global freight audit and payment solutions, transportation consulting, business intelligence dashboards, and various IT services such as cloud computing, cyber security, and managed IT services. The company also offers a unified commerce platform, order management systems, point of sale solutions, product information management, trading partner management, omni-channel fulfillment execution, ecommerce services, and Microsoft business solutions including Power BI, 365, SharePoint Partner, Azure, and Dynamics 365. enVista's expertise in data analytics and artificial intelligence further enhances its ability to help clients reduce operating costs, improve customer service, and enhance profitability across multiple industries.
SpaceClaim
Series C in 2009
SpaceClaim Corporation is a developer of 3D direct modeling software solutions designed to assist engineers, product designers, and manufacturers throughout the product development process. Founded in 2005 and headquartered in Concord, Massachusetts, with additional offices in France and Japan, the company offers several key products, including SpaceClaim Engineer for creating and preparing 3D designs, SpaceClaim Style for industrial design, and SpaceClaim Viewer for accessing and measuring designs. SpaceClaim also provides educational licenses and training programs to support learning institutions in North America. Its software is utilized for various applications, such as conceptual engineering, CAE/model preparation, and manufacturing engineering, and is distributed through a network of resellers both domestically and internationally.
FetchDog is an online destination for dog owners to shop, learn and socialize. They offer passionate dog people a place to find quality dog supplies and credible advice on their dog’s health and wellness. Their products include pets, dog beds, dog homes, dog collars, leashes and harnesses, dog apparel, dog toys, treats, bowls, dog travel, and more.
Adimab LLC is a biotechnology company specializing in the discovery, development, and optimization of human monoclonal and bispecific antibodies. Founded in 2007 and based in Lebanon, New Hampshire, Adimab utilizes a yeast-based platform to create therapeutic antibodies, including IgG and CD3-based bispecific antibodies. The company is recognized for its ability to deliver diverse and high-quality antibody panels that adhere to stringent standards for affinity, epitope coverage, and species cross-reactivity. This capability allows Adimab to support its partners in rapidly expanding their biologics pipelines through various technology access arrangements. The company's work primarily targets the treatment of cancer, autoimmune disorders, and infectious diseases.
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.
enVista
Venture Round in 2008
enVista LLC is a software development and consulting services company based in Carmel, Indiana, with additional offices in Columbus, Mississippi; Liverpool, United Kingdom; Hyderabad, India; and Houston, Texas. Founded in 2002, enVista specializes in providing solutions to manufacturers, distributors, and omni-channel retailers. The company offers a range of supply chain management services, including demand planning, workforce management, program management, facility design, systems selection and implementation, and supply chain partnerships. Additionally, enVista provides global freight audit and payment solutions, transportation consulting, business intelligence dashboards, and various IT services such as cloud computing, cyber security, and managed IT services. The company also offers a unified commerce platform, order management systems, point of sale solutions, product information management, trading partner management, omni-channel fulfillment execution, ecommerce services, and Microsoft business solutions including Power BI, 365, SharePoint Partner, Azure, and Dynamics 365. enVista's expertise in data analytics and artificial intelligence further enhances its ability to help clients reduce operating costs, improve customer service, and enhance profitability across multiple industries.
Makeover Solutions
Series A in 2007
Makeover Solutions, Inc., a marketing company, provides Web-based virtual makeovers. The company builds online communities for women users interested in beauty and beauty care conversations. Its Personal Makeover helps companies to create an online relationship with their customers. The company was incorporated in 2007 and is based in New York, New York.
SpaceClaim
Series B in 2007
SpaceClaim Corporation is a developer of 3D direct modeling software solutions designed to assist engineers, product designers, and manufacturers throughout the product development process. Founded in 2005 and headquartered in Concord, Massachusetts, with additional offices in France and Japan, the company offers several key products, including SpaceClaim Engineer for creating and preparing 3D designs, SpaceClaim Style for industrial design, and SpaceClaim Viewer for accessing and measuring designs. SpaceClaim also provides educational licenses and training programs to support learning institutions in North America. Its software is utilized for various applications, such as conceptual engineering, CAE/model preparation, and manufacturing engineering, and is distributed through a network of resellers both domestically and internationally.
enVista LLC is a software development and consulting services company based in Carmel, Indiana, with additional offices in Columbus, Mississippi; Liverpool, United Kingdom; Hyderabad, India; and Houston, Texas. Founded in 2002, enVista specializes in providing solutions to manufacturers, distributors, and omni-channel retailers. The company offers a range of supply chain management services, including demand planning, workforce management, program management, facility design, systems selection and implementation, and supply chain partnerships. Additionally, enVista provides global freight audit and payment solutions, transportation consulting, business intelligence dashboards, and various IT services such as cloud computing, cyber security, and managed IT services. The company also offers a unified commerce platform, order management systems, point of sale solutions, product information management, trading partner management, omni-channel fulfillment execution, ecommerce services, and Microsoft business solutions including Power BI, 365, SharePoint Partner, Azure, and Dynamics 365. enVista's expertise in data analytics and artificial intelligence further enhances its ability to help clients reduce operating costs, improve customer service, and enhance profitability across multiple industries.
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.
Flurry, Inc. is a mobile application analytics and advertising platform that assists businesses in understanding and monetizing user interactions with their mobile applications. Founded in 2005 and headquartered in San Francisco, Flurry offers a comprehensive suite of products, including Flurry Analytics, which tracks consumer behavior across over 400,000 applications, providing insights into audience engagement and retention. The platform also features AppSpot for ad serving, AppCircle for audience building, Flurry Personas for targeted marketing, and Flurry Marketplace for streamlined access to advertisers. With more than 125,000 companies utilizing its services, Flurry handles over 1 billion end-user sessions monthly across various devices, including iOS, Android, and Windows Phone. Flurry is a subsidiary of Yahoo! Inc. as of 2014.
Handmark is a software development company specializing in applications for various mobile platforms including Android, Blackberry, Palm, and Windows. Their product portfolio spans across multiple categories such as games, personalization solutions, ringtones, utilities, tools, sports, business productivity, fitness health, news information, reference, and entertainment. Notably, they have developed the Tantao News Mobile Reader for BlackBerry smartphones, offering global and domestic news sourced from Chinese media outlets.
SpaceClaim
Series A in 2005
SpaceClaim Corporation is a developer of 3D direct modeling software solutions designed to assist engineers, product designers, and manufacturers throughout the product development process. Founded in 2005 and headquartered in Concord, Massachusetts, with additional offices in France and Japan, the company offers several key products, including SpaceClaim Engineer for creating and preparing 3D designs, SpaceClaim Style for industrial design, and SpaceClaim Viewer for accessing and measuring designs. SpaceClaim also provides educational licenses and training programs to support learning institutions in North America. Its software is utilized for various applications, such as conceptual engineering, CAE/model preparation, and manufacturing engineering, and is distributed through a network of resellers both domestically and internationally.
GlycoFi is a biotech company focused on developing biotherapeutics utilizing glycan optimization technology. Founded in 2000 and based in Lebanon, New Hampshire, the firm specializes in a proprietary protein manufacturing process that employs engineered yeast strains to achieve precise human glycosylation. This innovative approach enables the creation of therapeutic proteins, which are essential for drug development. GlycoFi aims to build its own pipeline of products while also collaborating with other pharmaceutical companies to enhance their drug offerings. In 2006, GlycoFi became a subsidiary of Merck & Co. Inc., further expanding its capabilities in the biotherapeutics field.
Newforma is a software company that specializes in project information management (PIM) solutions tailored for the architecture, engineering, and construction (AEC) industry. Founded in 2003 and based in Boston, Newforma aims to enhance collaboration among project teams and stakeholders by providing tools that manage emails, facilitate information retrieval, and streamline the sharing of large files and processing of submittals. The company's software is designed to connect firms with their project information and remote team members, ultimately improving project delivery outcomes. Newforma's solutions are currently utilized to manage information across over 1.4 million projects globally, helping clients increase productivity, mitigate risks, and focus more on design and client service.
Handmark is a software development company specializing in applications for various mobile platforms including Android, Blackberry, Palm, and Windows. Their product portfolio spans across multiple categories such as games, personalization solutions, ringtones, utilities, tools, sports, business productivity, fitness health, news information, reference, and entertainment. Notably, they have developed the Tantao News Mobile Reader for BlackBerry smartphones, offering global and domestic news sourced from Chinese media outlets.
Medical Metrx Solutions
Series B in 2003
Medical Metrx Solutions, Inc. (formerly Medical Media Systems) is a medical technology and services company providing diagnostic quality 3-D virtual models of patient anatomy built from CT and MR scan data using the company’s proprietary modeling software. The company’s models — which contain more precise quantitative measurement information than competitors’ offerings — are provided to interventional radiologists and vascular surgeons who use them for pre-operative planning and post-operative surveillance of their patients’ conditions. The company was acquired by AIG Altaris Health Partners in 2005.